Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

16.2K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.2K
Mutations01:35

Mutations

41.1K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
41.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process.

Current oncology (Toronto, Ont.)·2024
Same author

Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer.

International journal of cancer·2024
Same author

Exposure Is More Than Distance or Time: The Evolution of Competence-Based Medical Education in Radiation Oncology Training.

International journal of radiation oncology, biology, physics·2024
Same author

Catalyzing the Next Generation: Interventions To Increase Medical Student Interest in Radiation Oncology.

International journal of radiation oncology, biology, physics·2023
Same author

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.

Practical radiation oncology·2022
Same author

A Favorable Entity Warranting the Right Therapy.

International journal of radiation oncology, biology, physics·2022

Related Experiment Video

Updated: Oct 4, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

Radiation dose for thymic tumours.

Nafisha Lalani1, Anthony M Brade2

  • 1Department of Radiation Oncology, University of British Columbia, Vancouver, Canada.

Mediastinum (Hong Kong, China)
|February 4, 2022
PubMed
Summary
This summary is machine-generated.

Post-operative radiotherapy (PORT) may improve local control for thymomas and thymic carcinomas after surgery. Further research is needed to establish optimal PORT doses and techniques for these rare thymic tumors.

Keywords:
Thymomaradiotherapythymic carcinoma

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

648
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Related Experiment Videos

Last Updated: Oct 4, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

648
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Radiation Oncology

Background:

  • Thymomas and thymic carcinomas are rare thymic epithelial tumors.
  • Surgical resection is the primary treatment, but complete removal can be challenging.
  • Local recurrences, often incurable, may occur after surgery.

Purpose of the Study:

  • To review current literature on radiotherapy indications for thymic tumors.
  • To explore dose-response relationships for post-operative radiotherapy (PORT).
  • To identify needs for future research in managing thymic malignancies.

Main Methods:

  • Systematic literature review of studies on PORT for thymomas and thymic carcinomas.
  • Analysis of existing data on radiotherapy indications and outcomes.
  • Exploration of dose-response relationships and toxicity considerations.

Main Results:

  • Limited literature exists on PORT for thymic tumors.
  • Optimal PORT dose and techniques are not yet established.
  • PORT may improve local control but requires careful toxicity management.

Conclusions:

  • PORT is a potential adjuvant therapy for thymic tumors, especially when complete resection is not achieved.
  • Further prospective studies are essential to define optimal radiotherapy strategies.
  • Balancing efficacy and toxicity is crucial for long-term patient management.